Alzheimer's is a devastating disease that has no cure. In the United States, more than 5.3 million Americans currently have the condition, and unless new treatments are developed, the number of people suffering from the disease will almost triple by 2050.
With the depressing statistics firmly in mind, researchers are rushing to develop treatments that will at least slow — but hopefully cure and even prevent the disease.
Here are two promising developments:
Telomerase treatment. Dr. Michael Fossel, author of The Telomerase Revolution and co-founder of the bio-tech company Telocyte, is petitioning the FDA to start human trials on a treatment he believes will cure Alzheimer's. Fossel, a former emergency room physician, has studied aging for 30 years, and he says that an enzyme called telomerase is key to conquering the diseases of aging, including Alzheimer's.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
6 comments:
I'm sorry, what were you writing about? I forgot.
Sad that research has taken so long, my father, who has alzheimers, may not be lucky enough to benefit from this. It is a sad, debilitating disease.
He will die in an "accident" and his research will "disappear" or be discredited by the paid "scientists" of Big Pharma.
He is playing with BILLIONS of dollars going to insurance payments, nursing homes, pharmaceutical companies, lawyers, lobbyists, 'representatives', and health care companies. You really think they are going to give that up without a murder or two???
He should hire some bodyguards.
So true 8:25, thats how big pharma works!
what happened to the 15 yo Annapolis boy who discovered a litmus test for several kinds of cancer?
dear God, how I pray that he has.
Post a Comment